v3.22.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:        
Research and development (including related party purchases of $583 and $464 for the three months ended June 30, 2022 and 2021, respectively, $1,227 and $976 for the six months ended June 30, 2022 and 2021, respectively. $ 74,205 $ 54,034 $ 146,276 $ 88,218
Selling, general and administrative (including related party purchases of $128 and $131 for the three months ended June 30, 2022 and 2021, respectively, $289 and 236 for the six months ended June 30, 2022 and 2021, respectively) 25,177 14,336 47,449 25,980
Total operating expenses 99,382 68,370 193,725 114,198
Loss from operations (99,382) (68,370) (193,725) (114,198)
Interest and other income, net 2,583 229 3,371 709
Interest expense (29) (1,041) (60) (1,904)
Income from equity method investment 4,581 4,181 19,039 8,891
Gain from change in fair value of warrants and earnout shares 42,698 0 59,512 0
Total other income, net 49,833 3,369 81,862 7,696
Loss before income taxes (49,549) (65,001) (111,863) (106,502)
Income tax expense 25 5 30 9
Net loss $ (49,574) $ (65,006) $ (111,893) $ (106,511)
Earnings per share, basic (in dollars per share) $ (0.09) $ (0.58) $ (0.19) $ (0.96)
Earnings per share, diluted (in dollars per share) $ (0.09) $ (0.58) $ (0.19) $ (0.96)
Weighted average number of shares outstanding, basic (in shares) 581,265,924 111,898,795 580,184,274 111,458,101
Weighted average number of shares outstanding, diluted (in shares) 581,265,924 111,898,795 580,184,274 111,458,101

Source